Apricus Announces Laboratoires Majorelle to Market Vitaros in France, Monaco and Certain African Countries

By: Benzinga
Apricus Biosciences (NASDAQ: APRI ) announced today that Apricus signed an exclusive license agreement with Laboratoires Majorelle to market Vitaros®, its topical on-demand product for the treatment of erectile dysfunction ("ED"), in France, Monaco and certain African countries (the "Territory"). Under the terms of the agreement, Apricus is eligible to
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.